The assembly of clathrin/AP (adaptor protein)-1-coated vesicles on the trans-Golgi network and endosomes is much less studied than that of clathrin/AP-2 vesicles at the plasma membrane for endocytosis. In vitro, the association of AP-1 with proteinfree liposomes had been shown to require phosphoinositides, Arf1 (ADP-ribosylation factor 1)-GTP and additional cytosolic factor(s). We have purified an active fraction from brain cytosol and found it to contain amphiphysin 1 and 2 and endophilin A1, three proteins known to be involved in the formation of AP-2/clathrin coats at the plasma membrane. Assays with bacterially expressed and purified proteins showed that AP-1 stabilization on liposomes depends on amphiphysin 2 or the amphiphysin 1/2 heterodimer. Activity is independent of the SH3 (Src homology 3) domain, but requires interaction of the WDLW motif with γ -adaptin. Endogenous amphiphysin in neurons and transfected protein in cell lines co-localize perinuclearly with AP-1 at the trans-Golgi network. This localization depends on interaction of clathrin and the adaptor sequence in the amphiphysins and is sensitive to brefeldin A, which inhibits Arf1-dependent AP-1 recruitment. Interaction between AP-1 and amphiphysin 1/2 in vivo was demonstrated by co-immunoprecipitation after crosslinking. These results suggest an involvement of amphiphysins not only with AP-2 at the plasma membrane, but also in AP-1/clathrin coat formation at the trans-Golgi network.
INTRODUCTION
Membrane transport through the secretory and endocytic pathways is typically mediated by vesicles formed by coat proteins recruited to the donor membrane from the cytosol [1] . CCVs (clathrin-coated vesicles) are involved in endocytosis from the plasma membrane, as well as transport from the TGN (trans-Golgi network) and endosomes. Clathrin triskelia form a mechanical scaffold that is linked to membrane lipids and cargo proteins by APs (adaptor proteins) [2] . The major clathrin adaptors are the heterotetrameric complexes AP-2, involved in endocytosis from the plasma membrane, and AP-1, implicated in post-Golgi sorting. The formation of AP-2/CCVs is by far the best-characterized of these systems because of its accessibility at the cell surface and the easy functional assays for cargo internalization. AP-2 interacts with PtdIns(4,5)P 2 , the landmark lipid of the plasma membrane, via its α subunit [3] , to cargo proteins primarily via its μ2 subunit or α/σ 2 interface (via tyrosine and dileucine motifs respectively) [4] , and to a large network of accessory coat components mostly via its α and β2 appendages [5] . Interacting network components include alternative adaptors that expand the cargo spectrum (e.g. β-arrestin), lipid interactors that introduce membrane curvature (e.g. epsin), inducers of actin polymerization (e.g. intersectins), dynamin recruiters for vesicle fission [e.g. Amphs (amphiphysins)], and finally the lipid phosphatase synaptojanin and auxillin for uncoating. The interactome components stabilize each other, but also compete for binding sites and thereby alter the character of the network from one dominated by adaptors to first a clathrin-centred and finally a dynamin-controlled one [5] .
Considerably less is known about the components involved in the formation of clathrin coats at the TGN and endosomes where AP-1 serves as the adaptor complex and which are involved in mannose 6-phosphate receptor trafficking [6, 7] , basolateral sorting [8, 9] , endosome-to-TGN transport [10] and receptor recycling to the plasma membrane [11, 12] . To date, the GGAs [Golgi-associated γ -adaptin ear homology domain, Arf (ADPribosylation factor)-interacting protein], γ -synergin, rabaptin-5, epsinR, NECAP (adaptin ear-binding coat-associated protein), aftiphilin and γ -BAR (AP-1 complex-associated regulatory protein)/Gadkin are among the proteins known to bind γ 1-adaptin [13, 14] .
The minimal machinery for the recruitment of AP-1 to membranes was defined by in vitro assays using liposomal membranes [15] [16] [17] [18] [19] . Purified proteins and nucleotides were incubated with liposomes of defined lipid composition with or without covalently coupled peptides mimicking cargo proteins. The liposomes were separated by sedimentation or flotation and analysed for associated AP-1. It was observed that phosphoinositides, the activated small GTPase Arf1 and membrane-bound cargo signals are necessary and sufficient. However, in the presence of cytosol, Arf1-dependent membrane association of AP-1 could be also observed without sorting signals. This suggested that unknown cytosolic factors contribute to formation of AP-1/clathrin coats [15, 16] .
In the present study, we have used a liposome-flotation assay to identify cytosolic proteins collaborating with AP-1 at the membrane. Separation of proteins from bovine brain cytosol yielded a final active fraction containing Amph, Amph2 and endophilin A1. Using bacterially expressed proteins, the activity was found to be due to Amph2 and Amph1/2 heterodimers. In neuronal cells, Amphs were found to colocalize with AP-1 at the TGN and could be cross-linked to it. These findings suggest that Amphs and possibly other proteins, which so far are only known to play a role in the formation of AP-2/clathrin coats at the plasma membrane, are also involved in the formation of AP-1 carriers at the TGN.
EXPERIMENTAL Preparation of cytosol, CCVs, clathrin adaptors and Arf1
Bovine brain cytosol and CCVs were isolated, the coat proteins released from CCVs and mixed APs were purified as described previously [16, 20] . Cytosol (typically ∼25 mg/ml protein) was centrifuged at 4
• C for 30 min at 170 000 g immediately before use. Myristoylated Arf1 was purified as described by Liang and Kornfeld [21] .
To purify cytosolic AP-1, 1.5 mg of anti-γ -adaptin (100/3) was diluted in 50 mM Tris/HCl (pH 9), mixed with 1.2 ml of packed Protein A-Sepharose and incubated at room temperature (22
• C) for 1 h with end-over-end rotation. The beads were washed twice with 50 mM sodium borate (pH 9), resuspended in 20 ml of 0.2 M sodium borate with 20 mM dimethylpimelidate, incubated at room temperature for 30 min to covalently link the antibodies to the beads, washed and incubated with 20 ml of 0.2 M ethanolamine (pH 8), for 2 h to quench the reaction, washed and resuspended 1:1 in PBS. Cytosol (10 ml) supplemented with protease inhibitor cocktail (10 μg/ml each of leupeptin, pepstatin and aprotinin, 0.5 mM orthovanadate and 0.5 mM PMSF) was incubated with anti-γ -adaptin-coupled Protein A-Sepharose overnight at 4
• C, washed with 0.1 M Mes-NaOH (pH 6.6), 0.5 mM MgCl 2 and 1 mM EGTA. Bound AP-1 was eluted by incubating the beads three times with 1 ml of buffer containing protease inhibitors and a 100-fold molar excess over the antibody used of the competing epitope peptide DLLGDINLTGAPAAAPA for 30 min at 37
• C and stored at 4 • C.
Liposome-flotation assay
Liposomes were prepared from soya bean phospholipids (azolectin, containing about 20 % L-α-phosphatidylserine, Sigma-Aldrich) by extrusion through 400-nm nucleopore polycarbonate membranes as described previously [16, 20] . To prepare liposomes presenting cargo peptides, the lipid mixture was supplemented with 2.5 mol% N-[(4-maleimidylmethyl) cyclohexane-1-carbonyl]-1,2-dioleolyl-sn-glycero-3-phosphoethanolamine (Avanti Polar Lipids). Immediately after extrusion, these liposomes were incubated with 0.4 mg/ml of the synthetic peptide CRKRSHAGYQTI for 1 h at room temperature, stored at 4
• C and used within 3 days. In a total volume of 480 μl, 100 μl of liposomes (0.5 μmol of lipid) were mixed with 2 μg of Arf1, 0.2 mM GMP-PNP (guanosine 5 -[β,γ -imido]triphosphate), mixed adaptor or an isolated AP-1 preparation (10 μg or 4 μg of protein respectively), 1.5 mg/ml BSA to block unspecific binding, and 330 μl of either assay buffer [0.1 M Mes-NaOH (pH 6.6), 0.5 mM MgCl 2 , 1 mM EGTA and 0.2 mM DTT (dithiothreitol)] as the negative control, cytosol (1 mg of protein diluted in assay buffer) as the positive control or aliquots from cytosol fractionation (typically containing 100-150 μg of total protein) transferred into assay buffer by ultrafiltration (Amicon Ultra 15 from Millipore) or desalting (using PD10 gel-filtration columns, Bio-Rad Laboratories) and incubated at 37
• C for 30 min. The reaction was mixed with 480 μl of 60% (w/v) sucrose in assay buffer, placed into a 4-ml centrifuge tube, overlaid with 3 ml of 30 % sucrose in assay buffer and 0.18 ml of buffer, and centrifuged at 300 000 g for 1.5 h at 4
• C. The top 1-ml fraction containing the floated liposomes was collected and the recruited proteins were precipitated with 17 % (w/v) trichloroacetic acid after the addition of 5 μg of BSA as a carrier protein. Pellets were rinsed with acetone and dissolved by boiling in SDS sample buffer. Proteins were separated by SDS/PAGE (10-12.5 % gel), transferred on to polyvinylidene fluoride membranes (Millipore) for immunoblot analysis using anti-γ -adaptin (100/3) or anti-α-adaptin (AP.6) antibodies, a peroxidase-coupled secondary antibody and the ECL (enhanced chemiluminescence) reaction kit (Amersham Pharmacia Biotech).
Cytosol fractionation
Cytosol was supplemented with protease inhibitors, mixed with increasing amounts of saturated ammonium sulfate solution for 1 h at 4
• C and centrifuged for 30 min at 10 000 g. The final supernatant and redissolved pellet proteins were desalted into assay buffer.
Chromatography was performed at 4
• C using an FPLC system and columns from GE Healthcare. Protein precipitated from 20 ml of cytosol with 30 % (saturated) ammonium sulfate was redissolved in assay buffer, desalted on a PD10 column, supplemented with 2 M NaCl and loaded on to a HiPrep Phenyl FF hydrophobic-interaction column (high sub, 1.6 cm×10 cm). Bound proteins were eluted with a linear 200-ml gradient of 2-0 M NaCl. The fractions of highest activity were collected, concentrated to 2.5 ml in assay buffer by ultrafiltration, loaded on to a MonoQ 10/100 GL anion-exchange column (1.0 cm×10 cm) pre-equilibrated in assay buffer and eluted with a linear 80-ml gradient of 0-1 M NaCl.
MS
Proteins were cut from SDS/PAGE gels stained with either Coomassie Blue or silver. After in-gel digestion with trypsin, peptides were separated by capillary liquid chromatography using a 300SB C-18 column (Agilent Technologies) and analysed on an Orbitrap FT hybrid instrument (Thermo Finnigan). Proteins were identified using the SEQUEST software [22] against the NCBI non-redundant database.
Plasmid construction
Wild-type human Amph1 and Amph2 were cloned into the bacterial expression vector pET24d (Novagen) by PCR thus adding a C-terminal His 6 tag. Wild-type human endophilin A1 was cloned into the pGEX-4T-2 (GE Healthcare) fused to the C-terminus of GST (glutathione transferase). To generate the chimaeric construct Amph2M1, the middle domain of Amph2 (M2, residues 277-512) was replaced with the homologous portion of the middle domain of Amph1 (M1, residues 241-495). For Amph1 M1 , the second part of the Amph1 middle domain without a direct counterpart in the Amph2 sequence (M1 , residues 496-612) was deleted. For Amph1M2 and Amph1M2 M1 , M1 or the entire middle domain of Amph1 (M1 + M1 , residues 241-612) respectively, were replaced by M2.
Amph1-Myc and Amph2-FLAG were constructed by the addition of the respective epitope-encoding sequences to the 3 -end of the coding sequences and cloned into pcDNA3 (Invitrogen) for mammalian cell expression. Endophilin in pCMV6-ENTRY was purchased from OriGene. For Amph1 CLAP-Myc (where CLAP is clathrin and AP binding) and Amph2 CLAP-FLAG, codons 321-387 and 359-423 respectively, were deleted by PCR mutagenesis.
Expression and purification of Amph1, Amph2 and endophilin A1
Proteins were expressed in Escherichia coli BL21 cells upon induction with 0.5 mM IPTG (isopropyl β-Dthiogalactopyranoside) at 30
• C for 4 h (Amph1) or 37
• C for 6 h (Amph2). Cells were harvested and lysed in 50 mM Tris/ HCl (pH 8), 300 mM NaCl, 10 % glycerol and 10 mM imidazole by sonication. The lysate was clarified and applied to a 1 ml His-Trapp FF column (GE Healthcare). The column was washed with buffer containing 50 mM and 75 mM imidazole and eluted stepwise with 100 mM, 150 mM, 200 mM and 250 mM imidazole. To produce Amph1/2 heterodimers, Amph2 and C-terminally His 6 -tagged Amph1 were cloned into pETDuet-1 (Novagen), expressed in E. coli Rosetta 2 (DE3)pLysS cells upon induction with 0.5 mM IPTG for 4 h at 30
• C, and purified as above.
GST-endophilin A1 was expressed in E. coli BL21 cells upon induction with 1 mM IPTG at 37
• C for 4 h. Cells were lysed in 50 mM Tris/HCl (pH 8), 300 mM NaCl and 5 mM EDTA by sonication. Lysate was clarified and incubated with glutathioneSepharose 4B (GE Healthcare) for 1 h at 4
• C. The resin was washed with 20 volumes of buffer and eluted with 40 mM Lglutathione. Proteins were stored at − 80
• C. Anti-Amph1 (13), anti-Amph2 (N-19) and anti-endophilin (G-8) antibodies (Santa Cruz Biotechnology) were used for the immunoblot analysis.
Immunodepletion of Amph1 and AP-1
To deplete cytosol (1 mg of protein) of Amph1, Protein ASepharose beads (40 μl) were incubated with 8 μg of anti-Amph1 (8) antibody (Santa Cruz Biotechnology) in 1 ml of PBS overnight at 4
• C. The washed beads were incubated with 1 mg of cytosol in 1 ml of PBS for 2 h at 4
• C. After pelleting the beads, the supernatant was analysed for Amph1, Amph2 and endophilin by immunoblotting. Immunodepletion of AP-1 was performed similarly using 20 μg of anti-γ -adaptin (100/3) antibody to deplete 3.5 mg of cytosol.
Cell culture and immunofluorescence
Mouse cerebellar granule cells were isolated and cultured as described previously [23] . Cells were fixed after 10 days of culture. HN10, COS-1, PC12 and NIH 3T3 cells were grown in DMEM (Dulbecco's modified Eagle's medium) supplemented with 10 % FBS (fetal bovine serum; 5 % FBS and 10 % horse serum for PC12; 10 % FBS for NIH 3T3 cells), 100 units/ml penicillin, 100 units/ml streptomycin and 2 mM L-glutamine at 37
• C in 5% (HN10 and NIH 3T3 cells) or 7.5 % CO 2 (COS-1 and PC12 cells).
Cells were transiently transfected using FuGENE HD (Roche) and analysed 2 days after transfection. To induce differentiation, HN10 cells were cultured 1 day after transfection in serum-free high-glucose DMEM, with neuronal B-27 supplements [24] and 6 μM retinoic acid. Transfected cells were grown for 48 h on glass coverslips and fixed with 3 % paraformaldehyde for 10 min at room temperature. COS-1 cells were treated with 5 μg/ml BFA (brefeldin A) for 15 min before fixation.
Fixed cells were washed in PBS and permeabilized with 0.1 % Triton X-100 for 10 min. After blocking with 1 % BSA in PBS for 15 min, cells were incubated at room temperature with primary antibodies for 2 h in PBS containing 1 % BSA, washed and stained with fluorescent secondary antibodies in PBS containing 1 % BSA for 30 min. After a 5-min staining with Draq5 and several washes with PBS, the coverslips were mounted in Mowiol 4-88 (Hoechst). As primary antibodies, we used mouse monoclonal anti-FLAG (Sigma-Aldrich), anti-Amph1 (a gift from Professor Pietro de Camilli, Yale University, New Haven, CT, U.S.A.), antigiantin (from Professor Hans-Peter Hauri, Biozentrum, Basel, Switzerland), goat anti-AP-1 (Acris Antibodies), rabbit antiMyc (Abcam) and sheep anti-TGN46 (Serotec) antibodies. As secondary antibodies, non-cross-reacting A488-labelled goat anti-rabbit, A488-labelled donkey anti-goat and A546-labelled donkey anti-mouse Cy5 (indodicarbocyanine)-labelled antisheep immunoglobulin antibodies (Jackson ImmunoResearch and Amersham Biosciences) were used. The staining patterns were analysed using a Zeiss Confocal LSM510 microscope.
Coimmunoprecipitation
PC12 and NIH 3T3 cells were transfected with Amph1-Myc and Amph2-FLAG and cultured for 2 days. Alternatively, cerebellar granule cells were cultured as described above. To capture transient interactions, PC12 and NIH 3T3 cells were incubated with 2 mM DSP [dithiobis(succinimidyl propionate); ProteoChem] in 100 mM sodium phosphate (pH 7.8) for 30 min (10 min for cerebellar granule cells) at room temperature followed by the addition of 50 mM Tris/HCl (pH 7.5) for 15 min to stop the reaction. After washing, cells were lysed in 100 mM sodium phosphate (pH 8,) 1 % Triton X-100 and 2 mM PMSF for 1 h at 4
• C. The cleared lysate was incubated with anti-γ -adaptin (BD Transduction Laboratories) or anti-giantin (from Professor HansPeter Hauri) antibodies with 1 mg/ml BSA overnight at 4
• C, before antigen-antibody complexes were collected with Protein A-Sepharose for 1 h and washed four times with lysis buffer and PBS, boiled in SDS sample buffer and subjected to immunoblot analysis using anti-Amph1 (13), anti-Amph2 (N-19) (Santa Cruz Biotechnology and anti-γ -adaptin antibodies.
RNA interference
PC12 and NIH 3T3 cells were plated in 35-mm dishes and transfected with 20 nM siRNA (short interfering RNA) ONTARGETplus SMARTpool rat Amph1, mouse clathrin heavy chain or non-targeting control siRNAs (Dharmacon Thermo Scientific) using Lipofectamine TM RNAiMAX (Invitrogen). After 1 day, NIH 3T3 cells were transfected with Amph1-Myc and Amph2-FLAG as described above and cultured for 2 more days. After 3 days, cells were harvested in lysis buffer [0.5 % DOC (deoxycorticosterone), 1 % Triton X-100, 2 mM PMSF and protease inhibitor cocktail] for 1 h at 4
• C. After clearing the lysate, 100 μg of protein was used for immunoblot analysis.
Alternatively, cells were incubated with DSP cross-linker for co-immunoprecipitation or fixed with 3 % paraformaldehyde for immunofluorescence analysis as described above.
RESULTS

Cytosolic factors contribute to the membrane association of CCV-derived or cytosolic AP-1 to peptide-free liposomes
To assay for AP-1 membrane association and stabilizing factors, liposomes made of a rich soya bean lipid mixture were incubated at 37
• C for 30 min with purified myristoylated Arf1 and GMP-PNP, as well as with mixed adaptors isolated from bovine brain CCVs, and then floated on a sucrose-step gradient. The top fraction containing the floated liposomes was analysed for bound AP-1 by SDS/PAGE and immunoblotting using an antibody against the γ -subunit. As is shown in Figure 1(A) , coat-derived AP-1 was not bound to liposomes ( Figure 1A , lane 2) unless stabilized by cargo peptides coupled to the lipid membrane (lane 1, typically 30-50 % of input). In contrast, when full bovine brain cytosol was used as the source of AP-1, binding was equally efficient in the presence and absence of sorting peptides ( Figure 1A , lanes 3 and 4). To exclude that this is due to differences between coat-derived and free cytosolic adaptors, AP-1 was immunopurified from cytosol ( Figure 1B ). When tested in the flotation assay, cytosol-derived AP-1 associated to liposomes with sorting peptides, but not to those without ( Figure 1C , lanes 1 and 2), just like coat-derived AP-1. Yet AP-1-depleted cytosol enabled binding to peptide-free liposomes equally for both AP-1 preparations ( Figure 1C, lanes 4 and 5) . AP-1 association to these liposomes is thus mediated by a cytosolic component and is not due to different states of AP-1 (e.g. phosphorylation [25] ).
Purification and identification of cytosolic activity
To purify the cytosolic factors, bovine brain cytosol was first subjected to ammonium sulfate precipitation. Proteins precipitated up to 30 % ammonium sulfate saturation ( Figure 2A) were successively fractionated by hydrophobic interaction (Figure 2B ), anion-exchange (MonoQ; Figure 2C ) and cation-exchange (MonoS) chromatography ( Figure 2D ). Fractions were tested for AP-1 binding to liposomes after buffer exchange to assay conditions. The fractions with highest activity were used as the starting material for the next separation.
The fractions of the final MonoS chromatography were analysed for their protein composition by SDS/PAGE and Coomassie Blue staining (Figure 3 , left-hand panel). The strongest activity was present in fractions 6 and 7 whose major bands had apparent molecular masses of ∼120, ∼85 and ∼40 kDa. When incubated with liposomes under assay conditions, all three proteins associated with the membranes, since they could be recovered with the floated liposomes (Figure 3, right-hand panel) . By MS they were identified as Amph1, Amph2 and endophilin A1.
Amph1, Amph2 and endophilin A1
All three proteins are known components of the AP-2/clathrin interactome at the plasma membrane [5] . As illustrated in Figure 4 (A), they all contain a C-terminal SH3 domain and an N-BAR [N-terminal amphipathic helix-BAR (Bin-Amph-Rvs)] domain that mediates dimerization and forms a crescent-shaped positively charged surface to bind and shape curved membranes [26] . Amph1 and Amph2 are homologous proteins with 55 % identity. They in addition include a middle domain (M1 and M2 in Figure 4A ) that is partially duplicated (M1 ) in Amph1. Amph1 is expressed highest in neurons and concentrated at presynaptic terminals [27] . Amph2 is expressed in ten different splice variants with different tissue and intracellular distributions [including muscle-specific and ubiquitous forms named BIN1 (bridging integrator 1)], the longest splice variant being largely brain specific [27, 28] . Both full-size Amphs were shown to bind clathrin heavy chain and the AP-2 α-appendage through distinct, but partly overlapping, sites in a CLAP segment within their middle domains [29] [30] [31] . The SH3 domains of all three proteins interact with dynamin and synaptojanin [32] [33] [34] [35] . The SH3 domain of endophilin furthermore binds to a proline-rich segment in the middle domains of Amph1 and Amph2 [36] . Endophilin A1 is almost entirely specific to the brain [37] . Interestingly, the peptide SIPWDLWEPT (including the distal clathrin-binding motif PWDLW) of Amph2 fused to GST was shown to bind in vitro to AP-1 and AP-2 from brain cytosol [38] and to the isolated γ -appendage of AP-1 [39] . An interaction of full-length Amph1 or Amph2 with AP-1 had not been shown so far. 
Figure 3 Identification of proteins in final active fractions
Aliquots of fractions 4-9 eluted in the final MonoS chromatography shown in Figure 2 were analysed by SDS/PAGE and stained with Coomassie Blue. In addition, liposomes were incubated with fractions 6 and 7, floated to the top of a sucrose gradient, collected, trichloroacetic precipitated, separated by SDS/PAGE and stained with silver. Bands were excised and analysed by MS. The major bands were identified as Amph1, Amph2 and endophilin A1. In addition, spectrin was detected, yet in a distribution not matching maximal activity (horizontal lines). Molecular mass is shown on the left-hand side in kDa. 
Amph2 mediates liposome association of AP-1 via the WDLW motif in its middle domain
To confirm the identity of the protein(s) in the final fraction of Figure 3 that is responsible for AP-1 membrane association, Amph1 and Amph2 with a C-terminal His 6 tag, and GSTtagged endophilin A1 were expressed in bacteria and purified ( Figure 4B) . A significant fraction of each was recovered with liposomes in a flotation experiment ( Figure 4C ), confirming their ability to bind to membranes. Titration of purified Amph2 (0.1-50 μg/assay) in the AP-1 flotation assay revealed dosedependent activity above 2 μg/assay ( Figure 5A, lanes 1-6) . Amph1 and endophilin ( Figure 5A , lanes 11 and 12 and lanes 14-17 respectively) showed no consistent membrane association of AP-1 even at the highest concentrations. This was somewhat unexpected in the case of Amph1, since it comprises an identical WDLW motif as Amph2, however in a different environment. Mutant Amph1 and Amph2 lacking the SH3 domain or mutated in the adaptor-binding motif (WDLW to ADLA) were produced ( Figure 4B ) to test their contribution to liposome association of AP-1. Deletion of the SH3 domain had no effect on Amph2 activity and did not activate Amph1 ( Figure 5B, lanes 5-8) . The latter rules out autoinhibition of adaptor binding by intramolecular interaction of the SH3 domain with the proline-rich segment in the middle domain as a cause for inactivity of full-length Amph1, a regulatory mechanism shown to control clathrin binding [40] . In contrast, the WW→AA mutation in Amph2 strongly reduced AP-1 association to liposomes ( Figure 5B , lanes 9 and 10 compared with lanes 1 and 2), confirming that the WDLW motif contributes to AP-1 binding.
Amph1 and Amph2 had been shown in vivo to exist as heterodimers [27] . The fact that all three proteins were isolated together in our purification and the known interaction of endophilin with the Amphs suggests that they might form a functional complex. To test this, the three proteins were mixed in different combinations in the assay. The mixtures did not enhance AP-1 membrane association beyond that expected for the contribution of Amph2 in the mixture ( Figure 5C ). Accordingly, a ternary mixture with the WW→AA mutant of Amph2 showed no activity ( Figure 5C, lane 8) . Since the Amphs are known interactors of AP-2, their ability to stabilize AP-2 on the liposomes was also tested by immunoblotting for α-adaptin in the floated fraction. Amph2 efficiently mediated AP-2 association with the liposomes ( Figure 5D, lane 1) . Upon mutation of the WDLW motif, this was reduced to a lower level of activity that was also observed with Amph1 and Amph1WWAA ( Figure 5D, lanes 2-4) . This basal WDLW-independent activity is most likely to be due to the AP-2-interaction sequences further upstream in the CLAP domain that have been identified by pull-down experiments using GST-fusion proteins [31, 41] and that are not functional for AP-1.
Immunodepletion of bovine brain cytosol using an antibody directed against Amph1 depleted both Amphs (but not endophilin; Figure 6A ), confirming that essentially all of Amph2 is quite stably associated with Amph1 [27] . Since dimerization via the BAR domain may not be readily reversible, His 6 -tagged Amph1 and untagged Amph2 were co-expressed from a dualexpression plasmid in bacteria and purified by Ni-NTA (Ni 2 + -nitrilotriacetate) chromatography. This preparation (Amph1/2), in which all of the Amph2 is in heterodimers, was tested in comparison with a mixture of corresponding amounts of separately purified Amph1 and Amph2 ( Figure 6B , Amph1 and Amph2). The two samples showed equal AP-1 membranebinding activity as Amph2 alone ( Figure 6C ), confirming that the heterodimeric Amph1/2 is active for AP-1 association to liposomes at a level comparable with the Amph2 homodimers.
It is surprising that Amph1 did not mediate AP-1 binding to membranes, even though it was functional in binding clathrin and AP-2 in GST-fusion pull-down experiments [31, 38] and contains a WDLW motif as is necessary for the activity of Amph2. We tested whether the additional middle domain sequence M1 , which has no counterpart in Amph2, is responsible for this by deleting it. Furthermore we exchanged the middle domains M1 and M2 between Amph1 and Amph2. The results (Supplementary Figure S1 at http://www.biochemj.org/bj/450/bj4500073add.htm) indicated that the WDLW motif alone is not sufficient for AP-1 stabilization on the membrane and that the sequence context within the middle domain is important for the productive presentation of the interaction sequences.
Amph1/2 localizes with AP-1 at the TGN in vivo
To assess a participation of Amph in AP-1/clathrin coats in vivo, primary cultures of cerebellar granule cells were subjected to immunofluorescence localization of endogenous Amph and AP-1 ( Figure 7 ). Amph1 was found to co-localize with AP-1 in its typical perinuclear accumulation corresponding to the position of the TGN. Similarly, in the neuronal HN10 cell line, whose endogenous Amph levels are too low to be detectable by immunofluorescence with the available antibodies, co-transfected Amph1 and Amph2 tagged with Myc and FLAG epitope tags respectively, localized to the cell surface as well as to the perinuclear region ( Figure 8A ) and co-localized with AP-1 at the TGN ( Figure 8B ). The expressed endophilin, in contrast, did not localize to the Golgi region ( Figure 8C ).
When Amph1 and Amph2 constructs lacking the CLAP domains were expressed, their perinuclear concentration and colocalization with AP-1 were lost ( Figure 8D ), demonstrating that TGN localization is owing to the sequences involved in adaptor and clathrin binding. Upon expression of mutant Amphs lacking the CLAP domains or of wild-type Amph1 and Amph2 in nonneuronal COS-1 cells, the same phenotypes as in HN10 cells were observed ( Figures 9A and 9B) . Furthermore, treatment of cells with BFA, an inhibitor of the guanine nucleotide exchange factors BIG (BFA-inhibited guanine nucleotide-exchange protein) 1 and BIG2 of Arf1 that blocks the recruitment of AP-1 to the membrane [42] , caused both AP-1 and Amph1 to dissociate from the TGN (Figure 9C ), whereas the localization of TGN46, a transmembrane marker of this organelle, was unchanged ( Figure 9D ). This observation strongly supports the notion that Amphs are localized to the TGN by interaction with AP-1/clathrin coat components.
To test a possible physical interaction between AP-1 and Amphs in neuronal cells, co-immunopreciptation experiments were performed either without or with prior cross-linking to capture transiently interacting partner proteins (Figure 10 ). Amphs could not be detected with immunoprecipitated AP-1 without crosslinking. However, when the intact cells were incubated with the bifunctional membrane-permeant cross-linker DSP before lysis and immunoprecipitation, both Amph1 and Amph2 (transfected into PC-12 cells or endogenous in primary cerebellar granule cells; Figures 10A and 10B respectively) were co-isolated. The interaction was specific, since no signal was obtained using an antibody against the unrelated Golgi protein giantin. This finding confirms the notion that in cells expressing Amphs they are recruited to nascent AP-1/clathrin coats at the TGN. In cells in which clathrin levels were strongly reduced by siRNA silencing, no significant change in cross-linking of Amph1 and Amph2 to AP-1 was observed ( Figure 10C ), indicating that it is not primarily the interaction with clathrin that recruits Amphs to the nascent AP-1 coat. On the other hand, depletion of Amphs by siRNA silencing of Amph1 in PC12 cells did not detectably affect AP-1 localization to the TGN (Supplementary Figure S2 at http://www.biochemj.org/bj/450/bj4500073add.htm), supporting the notion that AP-1 does not require Amph1/2 for membrane recruitment even in neuronal cells that normally express Amph1/2.
DISCUSSION
In vitro reconstitution helps to define minimal mechanisms of physiological processes. In this manner it was shown that multiple interactions are required to recruit AP-1 adaptors to a liposomal membrane: interactions of AP-1 with specific lipids, active membrane-bound Arf1-GTP and membrane-anchored cargo peptides [15] [16] [17] . Cargo binding induces AP-1 to oligomerize and to enhance its association with Arf1-GTP [17] [18] [19] producing a scaffold with multivalent membrane attachment. The observation that cytosolic proteins contribute to AP-1 association with liposomes in the absence of cargo in a lipidand Arf1-dependent manner indicated the existence of additional factors that stabilize AP-1 on the membrane [15, 17] . Purification of this activity from brain cytosol yielded a fraction containing Amph1, Amph2 and endophilin A1. Using bacterially expressed and purified proteins, we show in the present paper that Amph2, both alone and as a heterodimer with Amph1, is responsible for this in vitro activity.
All three proteins are known to play a role in clathrin-coat formation with AP-2 at the plasma membrane for endocytosis. The connectivity view of endocytic vesicle formation suggests the dynamic progression of a complex network of proteins that is initiated by FCHo1/2 (FCH domain-only protein 1/2) [43] , matures to an AP-2-centred network mediating cargo selection, then to a clathrin-dominated one at the time of coat assembly, and finally to one dominated by dynamin to bring about vesicle fission [5, 44] . BAR domain proteins are involved in the entire process, shaping the membrane to increasing curvatures. The Amphs and endophilin appear to act in the late steps of AP-2/CCV formation. With their SH3 domain, they interact with dynamin, activating its HN10 cells were co-transfected with Myc-tagged Amph1 and FLAG-tagged Amph2 and stained for Amph1-Myc and Amph2-FLAG (A) or for Amph2-FLAG and AP-1 (B). In essentially all cells, both Amphs were expressed and co-localized in the perinuclear region together with AP-1. In contrast, transfected endophilin-FLAG (Endo) did not localize to the TGN (C), nor did co-expressed Myc-tagged Amph1 and FLAG-tagged Amph2 both lacking the CLAP domain ( CLAP; D). Scale bars, 10 μm. Nuclei were stained with Draq5 (blue).
GTPase for vesicle fission [32, 45] , and with the lipid phosphatase synaptojanin in preparation for uncoating [33] . Their N-BAR domains are highly curved matching the highest membrane curvatures at deeply invaginated pits and the narrow neck before fission [46] . Analysis of the recruitment dynamics of fluorescent protein-tagged endocytic proteins showed the appearance of the Amphs and endophilin shortly before membrane fission after AP-2 and clathrin have assembled [47] .
The protein network associated with AP-1-dependent CCV formation at the TGN or endosomes has been characterized much less extensively. Our finding that Amph1/2 heterodimers support in vitro membrane association of AP-1 adaptors strongly suggests that these proteins are also involved in the process of AP-1/CCV formation. By analogy, they are likely to perform a very similar late function as with AP-2, i.e. binding and regulation of fission and uncoating factors (such as dynamin and synaptojanin) just before vesicle release. In fact, in similar assays as we have used in the present study, Amphs were also shown to stabilize AP-2 on liposomes. Di Paolo et al. [48] showed that the association of cytosolic AP-2 and clathrin with liposomes was reduced when brain cytosol from Amph1-knockout mice (lacking both the Amph1 and Amph2 proteins) was used. Similarly, purified Amph1 stimulated clathrin binding to liposomes [40] . As shown in Figure 5 (D), Amph2, and to a lesser extent Amph1, also mediated the membrane association of AP-2. In vitro membrane association reflects the mutual stabilization of coat components (adaptors and clathrin) and Amphs or other interactors on the membrane. This notion is emphasized by the network view of coat formation [5] .
In the middle domains of Amph1 and Amph2, partially overlapping interaction sites for AP-2 and clathrin had previously been identified [31, 41, 49] . The PWDLW motif of Amph1 was first established as a binding site for clathrin, but not AP-2, using GST fusions with various middle domain fragments [31] . Yet, the short peptides TLPWDLWTTS and SIPWDLWEPT derived from Amph1 and Amph2 respectively, fused to GST were found to pull down AP-1 and AP-2 in addition to clathrin from the brain cytosol [38] and the Amph2 peptide SIPWDLWEPT to bind directly to the appendage domain of γ -adaptin [39] . Several proteins have been shown to contain WXXW/F motifs that mediate selective binding to either the α-appendage of AP-2 [e.g. synaptojanin, AAK1 (AP2-associated protein kinase 1), GAK (cyclin-G-associated kinase), NECAP1, connecdenn and stonin Myc-tagged Amph1 and FLAG-tagged Amph2 both lacking the CLAP domain ( CLAP) were co-expressed in COS-1 cells and stained for FLAG and for endogenous AP-1 (A). Furthermore, cells expressing full-size Myc-tagged Amph1 and FLAG-tagged Amph2 were incubated without (B) or with (C and D) 5 μg/ml BFA, which prevents Arf1-dependent recruitment of AP-1 to the TGN, before fixation and staining for Amph2 and AP-1 (C) or TGN46 (D). Scale bars, 20 μm. [50] [51] [52] [53] ) or to the γ -appendage of AP-1 (NECAP1 [separate from the motif recognizing α-adaptin] and in GGA1 [39] ). The WDLW motifs of Amph1 and Amph2 thus seem exceptional in that they have the potential to interact with both adaptor complexes, as is uncovered when presenting them as short peptides.
The liposome assay used here goes beyond a simple pull-down experiment, since it involves stabilization of an adaptor complex interacting with lipids and Arf1-GTP on a bilayer. It thus includes the specific arrangement of both AP-1 and the Amph dimer on the membrane surface. The results demonstrate that full-length Amph2 interacts with AP-1 via its WDLW motif, either alone or as a heterodimer with Amph1, whereas Amph1 alone does not. The domain-swapping experiments (Supplementary Figure S1) suggest that the WDLW motif in M1 is not functional (particularly the downstream flank is very different from that in Amph2) and that in addition the M1 repeat sequence may reduce accessibility.
Purified endophilin had no activity in the liposome assay. Endophilin had been shown to interact in vitro with Amph1/2 via its SH3 domain [36] , which may explain their co-purification. Yet, endophilin was not co-depleted with Amph1 ( Figure 6A ), in agreement with a previous report [54] .
Importantly, Amphs and endophilins are not generally essential for AP-2/CCV formation, since Amph1, the CLAP domaincontaining splice-variants of Amph2, and endophilin A1 are almost exclusively expressed in the brain [27, 28, 37] . They may thus perform an important enhancing function at sites of high transport demand such as in stimulated neurons. Amph1-knockout mice, which in parallel also lost Amph2 selectively in brain, were viable and largely normal, except for rare seizures and some learning deficits [48] . Upon neuronal stimulation, defects in synaptic vesicle recycling could be detected, indicating a contribution of Amphs to the synaptic vesicle cycle under heavy load. Endophilin A1-knockout mice had no phenotype; only a triple-knockout of all three endophilins (A1-3) caused post-natal lethality and the accumulation of AP-2/CCVs at the synapses [55] .
Consistent with an involvement of Amph1/2 in AP-1/clathrin coat formation, we found endogenous Amph of cerebellar granule cell neurons as well as exogenously expressed Amph in the neuronal cell line HN10 and COS-1 fibroblasts to co-localize with AP-1 at the TGN. This localization requires the CLAP domain and is sensitive to BFA, but not to a knockdown of the levels of clathrin. It thus involves the interaction of Amphs with nascent AP-1 coats, which is further confirmed by the finding that the Amphs could be cross-linked to AP-1 in intact cells. In vivo, AP-1 does not depend on Amphs for membrane localization, not even in neuronal cells, but rather on other interaction partners of the forming coat. In their absence, however, a stabilizing effect of Amph1/2 on AP-1 recruitment is apparent in vitro.
An involvement of Amphs in clathrin coats at both the plasma membrane and the TGN mirrors that of Eps15 (epidermal growth factor receptor substrate 15), which has also been demonstrated to function with AP-2 for endocytosis of the epidermal growth factor receptor and with AP-1 for the exit of certain secretory proteins [56] . Similarly, p34 was identified to bind to both α-and γ -adaptin [57] . Together with this, the results of the present study suggest that the machineries for CCV formation with AP-1 and AP-2 at different locations in the cell share more components than previously anticipated.
There may also be roles of Amphs at endosomes. Amph2 has previously been co-localized with endosomal sorting nexin 4 [58] . Similarly, AMPH-1, the only Amph in Caenorhabditis elegans and lacking a CLAP domain, was shown to regulate endocytic recycling co-operatively with RME-1 (receptormediated endocytosis 1) [59] . In mammalian cells, knockdown of BIN1, an isoform of Amph2 lacking the CLAP domain, was found to cause endosomal accumulation of transferrin, and BIN1 colocalized with EHD1 (Eps15 homology-domain containing 1; the mammalian RME-1) on recycling endosomes [59] . These findings indicate that Amphs may play a conserved role in the endocytic recycling pathway, possibly even independently of a direct interaction with adaptors and clathrin. 
